Searching for Synthetic Opioid Rescue Agents. 2: Identification of an Ultra-Potent Synthetic Opioid Rescue Agent

Area of Science:

• Pharmacology
• Toxicology
• Emergency Medicine

Background:

• Ultrapotent synthetic opioids (UPSOs) pose a significant public health risk due to their high potency and association with mass casualty events.
• UPSOs are linked to severe medical phenomena like opioid-induced respiratory depression (OIRD) and wooden chest syndrome (WCS), contributing to their lethality.
• Current opioid reversal agents like naloxone (NLX) have limitations in fully addressing the effects of potent synthetic opioids.

Purpose of the Study:

• To identify and characterize a novel rescue agent for treating the toxic effects of UPSOs.
• To evaluate the efficacy of rescue agent 9 compared to naloxone in preclinical models.
• To explore a new therapeutic strategy targeting peripheral opioid receptors for OIRD reversal.

Main Methods:

• In vitro potency assays comparing rescue agent 9 and naloxone.
• In vivo studies in rats to assess the reversal of fentanyl- and carfentanil-induced ventilatory depression.
• Evaluation of fentanyl-induced vocal cord closure reversal in rats.
• Assessment of brain penetrance of rescue agent 9.

Main Results:

• Rescue agent 9 demonstrated higher potency than naloxone in vitro.
• Agent 9 fully reversed fentanyl- and carfentanil-induced ventilatory depression and fentanyl-induced vocal cord closure in rats.
• Unlike naloxone, agent 9 increased minute ventilation above normal levels in treated rats.
• Agent 9 exhibited limited brain penetrance.

Conclusions:

• Rescue agent 9 represents a potential breakthrough in managing UPSO toxicity.
• Targeting peripheral opioid receptors offers a novel and potentially safer strategy for reversing OIRD.
• Agent 9 serves as a promising lead compound for developing new antidotes against synthetic opioid overdose.